Evidence map›Paper›PMID 22085931›Full record

ArticleThe EMBO journal2012

Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1.

Alexandre Orthwein, Astrid Zahn, Stephen P Methot, David Godin, Silvestro G Conticello, Kazutoyo Terada, Javier M Di Noia

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Alexandre OrthweinLaboratory of Mechanisms of Genetic Diversity, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada.
Astrid Zahn
Stephen P Methot
David Godin
Silvestro G Conticello
Kazutoyo Terada
Javier M Di Noia
Montreal Clinical Research Institute · CAAzienda Usl Toscana Centro · ITKumamoto University · JPUniversité de Montréal · CA

Funding

Canadian Institutes of Health Research MOP-84543
6 · The paper itself

Abstract

The enzyme activation-induced deaminase (AID) deaminates deoxycytidine at the immunoglobulin genes, thereby initiating antibody affinity maturation and isotype class switching during immune responses. In contrast, off-target DNA damage caused by AID is oncogenic. Central to balancing immunity and cancer is AID regulation, including the mechanisms determining AID protein levels. We describe a specific functional interaction between AID and the Hsp40 DnaJa1, which provides insight into the function of both proteins. Although both major cytoplasmic type I Hsp40s, DnaJa1 and DnaJa2, are induced upon B-cell activation and interact with AID in vitro, only DnaJa1 overexpression increases AID levels and biological activity in cell lines. Conversely, DnaJa1, but not DnaJa2, depletion reduces AID levels, stability and isotype switching. In vivo, DnaJa1-deficient mice display compromised response to immunization, AID protein and isotype switching levels being reduced by half. Moreover, DnaJa1 farnesylation is required to maintain, and farnesyltransferase inhibition reduces, AID protein levels in B cells. Thus, DnaJa1 is a limiting factor that plays a non-redundant role in the functional stabilization of AID.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsCell Line, TumorCytidine DeaminaseFemaleHSP40 Heat-Shock ProteinsHumansMaleMiceMice, KnockoutMicroscopy, ConfocalAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDnaja1 protein, mouseHSP40 Heat-Shock Proteins

Identifiers

PMID22085931
PMCPMC3273393
OpenAlexW1526850610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.